These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 17032344)

  • 21. Comparison of soluble glycoprotein 130 and cardiac natriuretic peptides as long-term predictors of heart failure progression.
    Gwechenberger M; Pacher R; Berger R; Zorn G; Moser P; Stanek B; Huelsmann M
    J Heart Lung Transplant; 2005 Dec; 24(12):2190-5. PubMed ID: 16364870
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Copeptin in heart transplant recipients depends on kidney function and intraventricular septal thickness.
    Przybylowski P; Malyszko J; Malyszko JS
    Transplant Proc; 2010 Jun; 42(5):1808-11. PubMed ID: 20620528
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Baseline and 6-month B-type natriuretic peptide changes are independent predictors of events in patients with advanced heart failure awaiting cardiac transplantation.
    Campana C; Pasotti M; Klersy C; Alessandrino G; Albertini R; Magrini G; Ghio S; Tavazzi L
    J Cardiovasc Med (Hagerstown); 2009 Sep; 10(9):671-6. PubMed ID: 19444135
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diastolic function and BNP changes during exercise predict oxygen consumption in chronic heart failure patients.
    Ciampi Q; Borzillo G; Barbato E; Petruzziello B; Betocchi S; Villari B
    Scand Cardiovasc J; 2009 Feb; 43(1):17-23. PubMed ID: 18609042
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.
    von Haehling S; Jankowska EA; Morgenthaler NG; Vassanelli C; Zanolla L; Rozentryt P; Filippatos GS; Doehner W; Koehler F; Papassotiriou J; Kremastinos DT; Banasiak W; Struck J; Ponikowski P; Bergmann A; Anker SD
    J Am Coll Cardiol; 2007 Nov; 50(20):1973-80. PubMed ID: 17996563
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Copeptin: a novel, independent prognostic marker in patients with ischemic stroke.
    Katan M; Fluri F; Morgenthaler NG; Schuetz P; Zweifel C; Bingisser R; Müller K; Meckel S; Gass A; Kappos L; Steck AJ; Engelter ST; Müller B; Christ-Crain M
    Ann Neurol; 2009 Dec; 66(6):799-808. PubMed ID: 20035506
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prediction of outcome by neurohumoral activation, the six-minute walk test and the Minnesota Living with Heart Failure Questionnaire in an outpatient cohort with congestive heart failure.
    Hülsmann M; Berger R; Sturm B; Bojic A; Woloszczuk W; Bergler-Klein J; Pacher R
    Eur Heart J; 2002 Jun; 23(11):886-91. PubMed ID: 12042010
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic usefulness of anemia and N-terminal pro-brain natriuretic peptide in outpatients with systolic heart failure.
    Schou M; Gustafsson F; Kistorp CN; Corell P; Kjaer A; Hildebrandt PR
    Am J Cardiol; 2007 Nov; 100(10):1571-6. PubMed ID: 17996522
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of usefulness of each of five predictors of mortality and urgent transplantation in patients with advanced heart failure.
    Sachdeva A; Horwich TB; Fonarow GC
    Am J Cardiol; 2010 Sep; 106(6):830-5. PubMed ID: 20816124
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic utility of B-type natriuretic peptide assessment in stable low-risk outpatients with nonischemic cardiomyopathy after decompensated heart failure.
    Nishii M; Inomata T; Takehana H; Naruke T; Yanagisawa T; Moriguchi M; Takeda S; Izumi T
    J Am Coll Cardiol; 2008 Jun; 51(24):2329-35. PubMed ID: 18549918
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serial biomarker measurements in ambulatory patients with chronic heart failure: the importance of change over time.
    Miller WL; Hartman KA; Burritt MF; Grill DE; Rodeheffer RJ; Burnett JC; Jaffe AS
    Circulation; 2007 Jul; 116(3):249-57. PubMed ID: 17592074
    [TBL] [Abstract][Full Text] [Related]  

  • 32. C-terminal provasopressin (copeptin) is associated with left ventricular dysfunction, remodeling, and clinical heart failure in survivors of myocardial infarction.
    Kelly D; Squire IB; Khan SQ; Quinn P; Struck J; Morgenthaler NG; Davies JE; Ng LL
    J Card Fail; 2008 Nov; 14(9):739-45. PubMed ID: 18995178
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic role of B-type natriuretic peptide in patients with diabetes and acute decompensated heart failure.
    Aspromonte N; Feola M; Milli M; Scardovi AB; Coletta C; Carbonieri E; Giovinazzo P; Di Giacomo T; Barro S; Rosso GL; Ceci V; Milani L; Valle R
    Diabet Med; 2007 Feb; 24(2):124-30. PubMed ID: 17257273
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correlation of B type natriuretic peptides with clinical and echocardiographic parameters in heterogeneous population of patients with symptoms suggestive of heart failure.
    Piechota WN; Piechota WT; Bejm J; Wierzbowski R; Michałkiewicz D
    Adv Med Sci; 2006; 51():164-7. PubMed ID: 17357300
    [TBL] [Abstract][Full Text] [Related]  

  • 35. B-type natriuretic peptide (BNP) in patients undergoing mitral valve surgery.
    Filsoufi F; Rahmanian PB; Salzberg S; von Harbou K; Bodian CA; Adams DH
    J Card Surg; 2008; 23(6):600-5. PubMed ID: 18793229
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predictors of elevated NT-pro-BNP in cardiovascular patients without acute heart failure.
    Pfister R; Tan D; Thekkanal J; Hellmich M; Schneider CA
    Int J Cardiol; 2009 Jan; 131(2):277-80. PubMed ID: 17913264
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma copeptin levels and prediction of outcome in heart failure outpatients: relation to hyponatremia and loop diuretic doses.
    Balling L; Kistorp C; Schou M; Egstrup M; Gustafsson I; Goetze JP; Hildebrandt P; Gustafsson F
    J Card Fail; 2012 May; 18(5):351-8. PubMed ID: 22555263
    [TBL] [Abstract][Full Text] [Related]  

  • 38. B-type natriuretic peptide as a predictor of postoperative heart failure after aortic valve replacement.
    Nozohoor S; Nilsson J; Lührs C; Roijer A; Algotsson L; Sjögren J
    J Cardiothorac Vasc Anesth; 2009 Apr; 23(2):161-5. PubMed ID: 19167912
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Admission B-type natriuretic peptide levels and in-hospital mortality in acute decompensated heart failure.
    Fonarow GC; Peacock WF; Phillips CO; Givertz MM; Lopatin M;
    J Am Coll Cardiol; 2007 May; 49(19):1943-50. PubMed ID: 17498579
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pro-B-type natriuretic peptide levels in acute decompensated heart failure.
    Waldo SW; Beede J; Isakson S; Villard-Saussine S; Fareh J; Clopton P; Fitzgerald RL; Maisel AS
    J Am Coll Cardiol; 2008 May; 51(19):1874-82. PubMed ID: 18466803
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.